ZAI LAB LIMITED Capital Expenditures
ZAI LAB LIMITED (ZLAB) reported Capital Expenditures of $2.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- ZAI LAB LIMITED payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $1.31M, a 54.63% decline year-over-year.
- ZAI LAB LIMITED payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $1.20M, a 22.10% decline year-over-year.
- ZAI LAB LIMITED payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $677.00K, a 73.96% decline year-over-year.
- ZAI LAB LIMITED payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $3.00M, a 123.92% increase year-over-year.
- ZAI LAB LIMITED payments to acquire property, plant, and equipment for fiscal 2025 was $8.10M, a 43.20% increase from fiscal 2024.
- ZAI LAB LIMITED payments to acquire property, plant, and equipment for fiscal 2024 was $5.66M, a 21.56% decline from fiscal 2023.
- ZAI LAB LIMITED payments to acquire property, plant, and equipment for fiscal 2023 was $7.21M, a 70.67% decline from fiscal 2022.
- ZAI LAB LIMITED payments to acquire property, plant, and equipment for fiscal 2022 was $24.59M, a 34.38% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.50M 10-Q · filed 2026-08-06 | $3.18M derived: sum of 3 quarters · filed 2026-08-06 | $6.19M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $1.20M 10-Q · filed 2026-05-07 | $1.87M derived: sum of 2 quarters · filed 2026-05-07 | $4.88M derived: sum of 3 quarters · filed 2026-05-07 | $7.76M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $677.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.68M derived: sum of 2 quarters · filed 2026-02-26 | $6.57M derived: sum of 3 quarters · filed 2026-08-06 | $8.10M 10-K · filed 2026-02-26 | ||
| 2025-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $5.89M derived: sum of 2 quarters · filed 2026-08-06 | $7.42M 10-Q · filed 2025-11-06 | $10.02M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $4.42M 10-Q · filed 2026-08-06 | $7.02M derived: sum of 3 quarters · filed 2026-08-06 | $8.36M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $1.53M 10-Q · filed 2026-05-07 | $4.13M derived: sum of 2 quarters · filed 2026-05-07 | $5.48M derived: sum of 3 quarters · filed 2026-05-07 | $6.22M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.94M derived: sum of 2 quarters · filed 2026-02-26 | $4.68M derived: sum of 3 quarters · filed 2026-02-26 | $5.66M 10-K · filed 2026-02-26 | ||
| 2024-09-30 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.08M derived: sum of 2 quarters · filed 2025-11-06 | $3.06M 10-Q · filed 2025-11-06 | $3.28M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-06-30 | $741.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.72M 10-Q · filed 2025-08-07 | $1.94M derived: sum of 3 quarters · filed 2026-02-26 | $3.69M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2024-03-31 | $974.00K 10-Q · filed 2025-05-08 | $1.20M derived: sum of 2 quarters · filed 2026-02-26 | $2.95M derived: sum of 3 quarters · filed 2026-02-26 | $4.67M derived: sum of 4 quarters · filed 2026-02-26 | ||
| 2023-12-31 | $222.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.98M derived: sum of 2 quarters · filed 2026-02-26 | $3.70M derived: sum of 3 quarters · filed 2026-02-26 | $7.21M 10-K · filed 2026-02-26 | ||
| 2023-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.48M derived: sum of 2 quarters · filed 2024-11-12 | $6.99M 10-Q · filed 2024-11-12 | $11.40M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | $1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $5.23M 10-Q · filed 2024-08-06 | $9.65M derived: sum of 3 quarters · filed 2025-02-27 | $16.33M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | $3.51M 10-Q · filed 2024-05-08 | $7.93M derived: sum of 2 quarters · filed 2025-02-27 | $14.61M derived: sum of 3 quarters · filed 2025-02-27 | $18.36M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $11.10M derived: sum of 2 quarters · filed 2025-02-27 | $14.84M derived: sum of 3 quarters · filed 2025-02-27 | $24.59M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | $6.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $10.43M derived: sum of 2 quarters · filed 2023-11-07 | $20.17M 10-Q · filed 2023-11-07 | $26.55M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-06-30 | $3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $13.49M 10-Q · filed 2023-08-07 | $19.87M derived: sum of 3 quarters · filed 2024-02-27 | $26.14M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2022-03-31 | $9.74M 10-Q · filed 2023-05-09 | $16.12M derived: sum of 2 quarters · filed 2024-02-27 | $22.39M derived: sum of 3 quarters · filed 2024-02-27 | $26.36M derived: sum of 4 quarters · filed 2024-02-27 | ||
| 2021-12-31 | $6.38M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $12.65M derived: sum of 2 quarters · filed 2024-02-27 | $16.61M derived: sum of 3 quarters · filed 2024-02-27 | $18.30M 10-K · filed 2024-02-27 | ||
| 2021-09-30 | $6.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $10.23M derived: sum of 2 quarters · filed 2022-11-09 | $11.92M 10-Q · filed 2022-11-09 | $11.92M 10-Q · filed 2021-11-09 | $17.21M derived: sum of 4 quarters · filed 2023-03-01 | |
| 2021-06-30 | $3.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $5.65M 10-Q · filed 2022-08-09 | $10.94M derived: sum of 3 quarters · filed 2023-03-01 | $14.47M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $1.68M 10-Q · filed 2022-05-10 | $6.98M derived: sum of 2 quarters · filed 2023-03-01 | $10.51M derived: sum of 3 quarters · filed 2023-03-01 | $10.77M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $5.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $8.83M derived: sum of 2 quarters · filed 2023-03-01 | $9.09M derived: sum of 3 quarters · filed 2023-03-01 | $10.13M 10-K · filed 2023-03-01 | ||
| 2020-09-30 | $3.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $3.79M derived: sum of 2 quarters · filed 2021-11-09 | $4.83M 10-Q · filed 2021-11-09 | $6.62M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-06-30 | $260.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.30M 10-Q · filed 2021-08-09 | $3.09M derived: sum of 3 quarters · filed 2022-03-01 | $3.26M derived: sum of 4 quarters · filed 2022-03-01 | ||
| 2020-03-31 | $1.04M 10-Q · filed 2021-05-10 | $2.83M derived: sum of 2 quarters · filed 2022-03-01 | $3.00M derived: sum of 3 quarters · filed 2022-03-01 | |||
| 2019-12-31 | $1.78M derived: 10-K 12 month − 6-K 9 month · filed 2022-03-01 | $1.96M derived: sum of 2 quarters · filed 2022-03-01 | $6.04M 10-K · filed 2022-03-01 | |||
| 2019-09-30 | $173.18K derived: 6-K 9 month − 6-K 6 month · filed 2020-01-21 | $4.25M 6-K · filed 2020-01-21 | ||||
| 2019-06-30 | $4.08M 6-K · filed 2020-09-11 | |||||
| 2018-12-31 | $123.10K derived: 10-K 12 month − 6-K 9 month · filed 2021-03-01 | $10.02M 10-K · filed 2021-03-01 | $10.02M 20-F · filed 2019-03-29 | |||
| 2018-09-30 | $9.89M 6-K · filed 2020-01-21 | |||||
| 2017-12-31 | $9.10M 20-F · filed 2020-04-29 | $9.10M 20-F · filed 2018-04-30 | ||||
| 2016-12-31 | $2.22M 20-F · filed 2019-03-29 | |||||
| 2015-12-31 | $738.47K 20-F · filed 2018-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |